HEAL Share Price Performance
Recent HEAL News & Updates
No updates
Restart Life Sciences Corp. Key Details
Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.013
- Gross Margin
- 0%
- Net Profit Margin
- 0%
- Debt/Equity Ratio
- 0%
Restart Life Sciences Corp. Competitors
About HEAL
- Founded
- 2004
- Employees
- n/a
- CEO
- WebsiteView website
Restart Life Sciences Corp., through its subsidiaries, operates as a biotechnology company worldwide. It engages in developing natural remedies specifically tailored for individuals on the autism spectrum; health-related foods that promote both mind and body wellness for healthy living, as well as psilocybin clinical trial for fragile X syndrome. The company was formerly known as Nova Mentis Life Science Corp. and changed its name to Restart Life Sciences Corp. in November 2024. Restart Life Sciences Corp. was incorporated in 2004 and is based in Vancouver, Canada.
Canadian Market Performance
- 7 Days: 0.2%
- 3 Months: 11.0%
- 1 Year: 18.3%
- Year to Date: 10.3%
Over the last 7 days, the market has remained flat, although notably the Industrials sector declined by 3.0%. As for the longer term, the market has risen 18% in the past 12 months. Looking forward, earnings are forecast to grow by 12% annually. Market details ›
Companies across the globe are beginning to pay attention to agentic AI. It’s also a term you’re likely to hear a lot during earnings season. In fact, it came up 26 times during...
Continue reading